Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.5780
+0.0074 (1.30%)
Oct 19, 2026, 1:34 PM EST
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $39.27 million as of October 19, 2026. It is the 32,155th most valuable company in the world and the 4,806th biggest in the United States. Its market cap has decreased by 13.29% in one year.
Market Cap
39.27M
Enterprise Value
41.18M
Revenue
n/a
Global Rank
Country Rank
#4,806 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has increased from 33.63M to 39.27M, an increase of 16.77%. That is a compound annual growth rate of 0.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 39.27M | -33.59% |
| Dec 31, 2025 | 59.13M | -32.56% |
| Dec 31, 2024 | 87.67M | 25.12% |
| Dec 29, 2023 | 70.07M | -46.02% |
| Dec 30, 2022 | 129.79M | -23.83% |
| Dec 31, 2021 | 170.40M | 138.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProText Mobility | 69.45M |
| NDT Pharmaceuticals | 63.05M |
| Nuo Therapeutics | 62.96M |
| Sangamo Therapeutics | 45.57M |
| Biomind Labs | 35.68M |
| Cell Source | 33.63M |
| ZIVO Bioscience | 26.99M |
| Aeternum Resources | 26.87M |